Categories

Breast Cancer

Pausing Endocrine Therapy to Become Pregnant Appears Safe for Women with Breast Cancer
By Patricia Stewart
Ribociclib plus Endocrine Treatment Outperforms Chemotherapy in Advanced Breast Cancer
By William King
CTC Count May Help Providers Choose Optimal Therapy for Patients with Metastatic Breast Cancer
By William King
View More Articles

FDA Updates

FDA News: January 27, 2023, to March 22, 2023
FDA News: December 9, 2022, and January 19, 2023
FDA News: October 21, 2021, and November 14, 2022
View More Articles

Supportive Care

Restrictive Diet May Not Be Necessary for Patients Undergoing HSCT
By Patricia Stewart
Psychosocial Issues in Patients with Cancer: It’s Time for Real-World Interventions
By Corbin Davis
Medical Cannabis in Patients with Advanced Cancer: Challenges Remain
By Corbin Davis
View More Articles

Lung Cancer

Case Study Finds Sotorasib Effective as First-Line Treatment for NSCLC With the KRAS G12C Mutation
NGS Found More Cost-Effective Than Single-Gene Testing in Patients With NSCLC
Liquid Biopsy Found to Be Feasible Alternative to Tissue Biopsy in NSCLC
View More Articles

In the News

CMS Expands Access to Telehealth Benefits During COVID-19 Outbreak
FDA Grants Priority Review to New Drug Application for the RET Kinase Inhibitor Selpercatinib
Tazverik Receives FDA Approval as First Treatment Specifically for Metastatic or Locally Advanced Epithelioid Sarcoma
View More Articles

Hematologic Cancers

Axicabtagene Ciloleucel Induces Durable Responses in Advanced Follicular Lymphoma and Marginal-Zone Lymphoma
By William King
CAR T-Cell Therapy Shows Highly Durable Remissions in CLL and B-Cell Lymphoma
By Charlie Dawson
November 4, 2019 — Oncology News & Updates
View More Articles
AACR Highlights
ACCC
Advance Care Planning
Alternative Medicine
AONN+ News
ASCO 2020 - Wrap Up
ASCO 2021 - Breast Cancer
ASCO 2021 Wrap-Up - Breast Cancer
ASCO 2023 GU
ASH 2019 Post Wrap-Up
ASH 2020 - Multiple Myeloma
ASH 2020 Highlights
ASH 2022
Ask the Experts
ASTRO 2022 Highlights
AUA Highlights
Audiocast
AVBCC 2019 Highlights
AVBCC COVID-19 Webcast Series
AVBCC Summit Highlights
Best Practices
Biomarkers
Biosimilars
Bladder Cancer
Breast Cancer
Cancer Awareness
Cancer Center Profile
Cancer Prevention
Cervical Cancer
Cholangiocarcinoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Clinical Pathways
Clinical Trials
COA Conference Highlights
Colorectal Cancer
Conference Correspondent
COVID-19
COVID-19 & Cancer
Diet and Nutrition
Digital Health
Disparities in Oncology
Drug Profiles
Drug Therapies
Drug Updates
Emerging Therapies
Endometrial Cancer
ESMO 2018
ESMO 2018 Wrap Up
ESMO 2022 Highlights
FDA Updates
Financial Toxicity
Financial/Insurance Information
From the Editor
Gastrointestinal Cancers
Genetic Counseling
Genetic Testing
Genitourinary Cancers
Genomic Testing
Geriatric Cancer
Gynecologic Cancers
Head and Neck Cancer
Health Disparities
Healthcare Disparities
Healthcare Equity
Healthcare Policy
Healthcare Technology
Hematologic Cancers
Hematologic Malignancies
Hepatocellular Carcinoma
Immunotherapy
In the Literature
In the News
Interview with the Innovators
Letters to the Editor
Leukemia
Lung Cancer
Lymphoma
Lynch Syndrome
MASCC/ISOO Conference Highlights
Master Class Series
Medical Marijuana
Melanoma
Mental Health
Multiple Myeloma
Myelodysplastic Syndromes
NCCN 2023 Conference Highlights
Neuroblastoma
Neuroendocrine Tumors
Noteworthy Numbers
NSCLC
Nursing
ONE Award
Online First
Original Research
Ovarian Cancer
Pain Management
Palliative Care
Pancreatic Cancer
Patient Advocacy
Pediatric Cancer
Perspective
Prostate Cancer
Quality Care Symposium
Rapid Reactions
Rare Cancers
Rectal Cancer
Renal-Cell Carcinoma
SABCS 2020 Highlights
SABCS 2023
Sarcoma
Sarlis Says
Side-Effects Management
Skin Cancer
Supplements
Supportive Care
Survivorship
Symptom Management
Thyroid Cancer
Urothelial Cancer
Value-Based Care

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

TON Print Edition

TON Weekly e‑Newsletter

I have reviewed and consent to the terms of TON's Privacy Policy, and TON has my permission to retain my information in its database, and to forward pertinent communications to me.